{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T18:14:52Z","timestamp":1780856092994,"version":"3.54.1"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.3621","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T22:01:20Z","timestamp":1426370480000},"page":"621-625","source":"Crossref","is-referenced-by-count":10,"title":["Insulinoma in a Patient with Chronic Renal Failure due to Type 2 Diabetes Mellitus Treated Effectively with Diazoxide"],"prefix":"10.2169","volume":"54","author":[{"given":"Masanori","family":"Shimizu","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Tsuchida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Anatomic and Diagnostic Pathology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Hiraishi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Aso","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moldow RE, Connelly RR. Epidemiology of pancreatic cancer in Connecticut. Gastroenterology 55: 677-686, 1968.","DOI":"10.1016\/S0016-5085(19)33985-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma: incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66: 711-719, 1991.","DOI":"10.1016\/S0025-6196(12)62083-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cryer PE. Mechanism of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 54: 3592-3601, 2005.","DOI":"10.2337\/diabetes.54.12.3592"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Suzuki K, Miyamoto M, Miyamoto T, Hirata K. Insulinoma with early-morning abnormal behavior. Intern Med 46: 405-408, 2007.","DOI":"10.2169\/internalmedicine.46.6071"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Okabayashi T, Shima Y, Sumiyoshi T, et al. Diagnosis and management of insulinoma. World J Gastroenterol 19: 829-837, 2013.","DOI":"10.3748\/wjg.v19.i6.829"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yao JC, Hassan M, Phan A, et al. One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26: 3063-3072, 2008.","DOI":"10.1200\/JCO.2007.15.4377"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Eng J Med 364: 514-523, 2011.","DOI":"10.1056\/NEJMoa1009290"},{"key":"8","unstructured":"8. Rindi G, Arnold R, Bosman FT, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification of Tumours of the Digestive System. 4th ed. Bosman FT, Carneiro F, Hruban RH, Theise ND, Eds. IARC Press, Lyon, 2010: 13-14."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kishikawa H, Okada Y, Hirose A, et al. Successful treatment of insulinoma by a single daily dose of octreotide in two elderly female patients. Endocr J 53: 79-85, 2006.","DOI":"10.1507\/endocrj.53.79"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Stehouwer CD, Lems WF, Fischer HR, Hackeng WH, Naafs MA. Aggravation of hypoglycemia in insulinoma by the long-acting somatostatin analogue octreotide (Sandostatin). Acta Endocrinol (Copenh) 121: 34-40, 1989.","DOI":"10.1530\/acta.0.1210034"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lorenz E, Alekseev AE, Krapivinsky GB, Carrasco AJ, Clapham DE, Terzic A. Evidence for direct physical association between a K<sup>+<\/sup> channel (Kir6.2) and an ATP-binding cassette protein (SUR1) which affects cellular distribution and kinetic behavior of an ATP-sensitive K<sup>+<\/sup> channel. Mol Cell Biol 18: 1652-1659, 1998.","DOI":"10.1128\/MCB.18.3.1652"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Garrino MG, Plant TD, Henquin JC. Effects of putative activators of K<sup>+<\/sup> channels in mouse pancreatic &beta;-cells. Br J Pharmacol 98: 957-965, 1989.","DOI":"10.1111\/j.1476-5381.1989.tb14626.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gill GV, Rauf O, MacFarlane IA. Diazoxide treatment for insulinoma: a national UK survey. Postgrad Med J 73: 640-641, 1997.","DOI":"10.1136\/pgmj.73.864.640"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Arao T, Okada Y, Hirose A, Tanaka Y. A rare case of adult-onset nesidioblastosis treated successfully with diazoxide. Endocr J 53: 95-100, 2006.","DOI":"10.1507\/endocrj.53.95"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Abe M, Kaizu K, Matsumoto K. Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose. Ther Apher Dial 11: 280-287, 2007.","DOI":"10.1111\/j.1744-9987.2007.00491.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pruitt AW, Faraj BA, Daytin PG. Metabolism of diazoxide in man and experimental animals. J Pharmacol Exp Ther 188: 248-256, 1974.","DOI":"10.1016\/S0022-3565(25)29746-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Cander S, G&uuml;l O&Ouml;, Yildirim N, Unal OK, Saraydaroglu O, Imamoglu S. A rare cause of hypoglycemia in a type 2 diabetic patient: insulinoma. J Diabetes Complications 26: 65-67, 2012.","DOI":"10.1016\/j.jdiacomp.2011.12.003"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nagai T, Imamura M, Takai Y, Mori M. Insulinoma accompanied by diabetes mellitus. Diabetes Res Clin Pract 60: 19-23, 2003.","DOI":"10.1016\/S0168-8227(02)00252-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kane LA, Grant CS, Nippoldt TB, Service FJ. Insulinoma in a patient with NIDDM. Diabetes Care 16: 1298-1300, 1993.","DOI":"10.2337\/diacare.16.9.1298"},{"key":"20","unstructured":"20. Ishii H, Ito T, Moriya S, Horie Y, Tsuchiya M. [Insulinoma-a statistical review of 443 cases in Japan]. Nihon Rinsho (Japanese Journal of Clinical Medicine) 51 (Suppl): 199-206, 1993 (in Japanese)."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:09:10Z","timestamp":1747786150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/6\/54_54.3621\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.3621","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}